Physician profile
Charles Daniel Bishop
NPI 1659560373
$2,281.44
in general payments reported to CMS, 2019-2025
5 companies · $83.92 in 2025
The $83.92 reported for 2025 was more than what a typical Endodontics provider received nationally (typical 2025 total: $58.83).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,931 · 2021: $31.61 · 2022: $104 · 2023: $131 · 2025: $83.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $156 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.62 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $867.04 | 2019-2025 | Endo Activator, Waveone Gold Conform Fit |
| Dentsply Ih INC. | $681.11 | 2019 | |
| Tulsa Dental Products LLC | $570.29 | 2019 | |
| J. Morita USA, INC. | $104.17 | 2022 | |
| Septodont INC. | $58.83 | 2025 | Bioroot Flow Sample |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.